The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Open accessAbstract
OBJECTIVE: Accumulating evidence links the intestinal microbiota and colorectal carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and inhibit T cell-mediated immune responses against colorectal tumours. Thus, we hypothesised that the amount of F. nucleatum in colorectal carcinoma might be associated with worse clinical outcome. DESIGN: We used molecular pathological epidemiology database of 1069 rectal and colon cancer cases in the Nurses' Health Study and the Health Professionals Follow-up Study, and measured F. nucleatum DNA in carcinoma tissue. Cox proportional hazards model was used to compute hazard ratio (HR), controlling for potential confounders, including microsatellite instability (MSI, mismatch repair deficiency), CpG island methylator phenotype (CIMP), KRAS, BRAF, and PIK3CA mutations, and LINE-1 hypomethylation (low-level methylation). RESULTS: Compared with F. nucleatum-negative cases, multivariable HRs (95% CI) for colorectal cancer-specific mortality in F. nucleatum-low cases and F. nucleatum-high cases were 1.25 (0.82 to 1.92) and 1.58 (1.04 to 2.39), respectively, (p for trend=0.020). The amount of F. nucleatum was associated with MSI-high (multivariable odd ratio (OR), 5.22; 95% CI 2.86 to 9.55) independent of CIMP and BRAF mutation status, whereas CIMP and BRAF mutation were associated with F. nucleatum only in univariate analyses (p<0.001) but not in multivariate analysis that adjusted for MSI status. CONCLUSIONS: The amount of F. nucleatum DNA in colorectal cancer tissue is associated with shorter survival, and may potentially serve as a prognostic biomarker. Our data may have implications in developing cancer prevention and treatment strategies through targeting GI microflora by diet, probiotics and antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Self-citationGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationGarrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,080
Self-citationSystemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Cited by
Sorted by citations
Items 501–600 of 1,000
Periodontal Pathogens Promote Foam Cell Formation by Blocking Lipid Efflux
Rho, J. H., Kim, H. J., Joo, J., Lee, J. Y., Lee, J. H., & Park, H. R. (2021) · Journal of Dental Research · doi:10.1177/00220345211008811 · Cited by 20
Nakayama, Y., Iijima, T., Inokuchi, T., Kojika, E., Takao, M., Takao, A., Koizumi, K., Horiguchi, S., Hishima, T., & Yamaguchi, T. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01968-y · Cited by 20
Preoperative iron status is a prognosis factor for stage II and III colorectal cancer
Sawayama, H., Miyamoto, Y., Mima, K., Kato, R., Ogawa, K., Hiyoshi, Y., Shimokawa, M., Akiyama, T., Kiyozumi, Y., Iwagami, S., et al. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01995-9 · Cited by 20
Self-citationHoang, T., Kim, M. J., Park, J. W., Jeong, S., Lee, J., & Shin, A. (2022) · BMC Cancer · doi:10.1186/s12885-022-09735-6 · Cited by 20
Guo, X., Wang, R., Chen, R., Zhang, Z., Wang, J., & Liu, X. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119732 · Cited by 20
Biological and Clinical Characteristics of Proximal Colon Cancer: Far from Its Anatomical Subsite
Yang, Q. Z., Qu, R., Lu, S., Zhang, Y., Zhang, Z., & Fu, W. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.97574 · Cited by 20
Targeted elimination of Fusobacterium nucleatum alleviates periodontitis
Yakar, N., Ünlü, Ö., Cen, L., Hastürk, H., Chen, T., Shi, W., He, X., & Kantarcı, A. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2388900 · Cited by 20
Praveen, M. A., Parvathy, K. R. K., Patra, S., Khan, M. I., Natarajan, P., & Balasubramanian, P. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.086 · Cited by 20
The gut microbiome and potential implications for early-onset colorectal cancer
Mukherji, R., & Weinberg, B. A. (2020) · Colorectal Cancer · doi:10.2217/crc-2020-0007 · Cited by 21
Yoshihara, T., Kioi, M., Baba, J., Usuda, H., Kessoku, T., Iwaki, M., Takatsu, T., Misawa, N., Ashikari, K., Matsuura, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03083-4 · Cited by 21
Gut microbiota in cancer initiation, development and therapy
Zhang, R., Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2831-x · Cited by 19
Interaction between gut microbiota and T cell immunity in colorectal cancer
Jing, Z., Wu, Y., Chu, J., Zhanbo, Q., Wu, X., & Han, S. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103807 · Cited by 20
Mucosa-associated bacteria and metabolites in inflammatory bowel disease: from inside to insight
Wang, X., He, L., Dong, Y., Qin, X., Zhang, H., Wang, B., Wang, S., & Cao, H. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00887-4 · Cited by 21
Lin, R., Han, C., Ding, Z., Shi, H., He, R., Liu, J., Qian, W., Zhang, Q., Fu, X., Deng, X., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.032 · Cited by 19
Application Value of Antimicrobial Peptides in Gastrointestinal Tumors
Liu, Q., Wang, L., He, D., Wu, Y., Liu, X., Yang, Y., Chen, Z., Dong, Z., Luo, Y., & Song, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316718 · Cited by 20
Xin, H., Zou, J., Sun, R., Hu, Z., Chen, Z., Luo, C., Zhou, Z., Wang, P., Li, J., Yu, S., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02090-2 · Cited by 19
Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review
El-Ghannam, M., Hassanien, M. H., Ameen, Y. A., Turky, E. A., ELattar, G. M., Ray, A. A. E., & Eltalkawy, M. D. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00340-9 · Cited by 20
Xin, Y., Yu, Y., Wu, M., Su, M., Elsabahy, M., Qu, X., & Gao, H. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.048 · Cited by 19
Qian, G., & Ho, J. W. K. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00724-2 · Cited by 20
Role and potential clinical utility of ARID1A in gastrointestinal malignancy
Wang, R., Chen, M., Ye, X., & Poon, K. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108360 · Cited by 20
The Viral Janus: Viruses as Aetiological Agents and Treatment Options in Colorectal Cancer
Turkington, C. J. R., Varadan, A. C., Grenier, S. F., & Grasis, J. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.601573 · Cited by 19
Sikavi, D. R., Nguyen, L. H., Haruki, K., Ugai, T., Ma, W., Wang, D. D., Thompson, K. N., Yan, Y., Branck, T. A., Wilkinson, J. E., et al. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000338 · Cited by 19
Self-citationThe Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer
Guo, Q., Qin, H., Liu, X., Zhang, X., Chen, Z., Qin, T., Chang, L., & Zhang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915047 · Cited by 21
Luu, K., Ye, J. Y., Lagishetty, V., Liang, F., Hauer, M. C., Sedighian, F., Kwaan, M. R., Kazanjian, K. K., Hecht, J. R., Lin, A., et al. (2023) · Nutrients · doi:10.3390/nu15020316 · Cited by 18
Tong, Y., Lu, G., Wang, Z., Hao, S., Zhang, G., & Sun, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1154818 · Cited by 18
Geier, D. A., & Geier, M. R. (2023) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4919 · Cited by 19
Li, J., Guo, Y., Liu, J., Guo, F., Du, L., Yang, Y. P., Li, X., & Ma, Y. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007420 · Cited by 18
Vigneswaran, J., & Shogan, B. D. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-020-04694-4 · Cited by 20
Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study
Cuellar‐Gomez, H., Ocharan-Hernández, M. E., Calzada‐Mendoza, C. C., & Comoto-Santacruz, D. A. (2021) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2021.07.001 · Cited by 22
Moxibustion may delay the aging process of Wistar rats by regulating intestinal microbiota
Ouyang, X., Duan, H., Jin, Q., Luo, X., Han, L., Zhao, B., Li, J., Chen, Y., Lin, Y., Liu, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112147 · Cited by 19
Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management?
Chen, B., Du, G., Guo, J., & Zhang, Y. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.009 · Cited by 18
Intratumoral Fusobacterium nucleatum in Pancreatic Cancer: Current and Future Perspectives
D’Antonio, D. L., Zenoniani, A., Umme, S., Piattelli, A., & Curia, M. C. (2024) · Pathogens · doi:10.3390/pathogens14010002 · Cited by 21
Phipps, A. I., Hill, C. M., Lin, G. I., Malen, R. C., Reedy, A. M., Kahsai, O. J., Ammar, H., Curtis, K. R., Ma, N., Randolph, T. W., et al. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100644 · Cited by 19
Self-citationFusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer
Sadeghloo, Z., Ebrahimi, S., Hakemi-Vala, M., Totonchi, M., Sadeghi, A., & Fatemi, N. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00757-6 · Cited by 18
Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
Ibragimova, S., Ramachandran, R., Ali, F. R., Lipovich, L., & Ho, S. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725821 · Cited by 18
Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?
Lin, Y., Kong, D.-X., & Zhang, Y.-N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852194 · Cited by 17
Diet, Microbes, and Cancer Across the Tree of Life: a Systematic Review
Kapsetaki, S. E., Alcaraz, G. M., Maley, C. C., Whisner, C. M., & Aktipis, A. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00420-5 · Cited by 19
Sambruni, G., Macandog, A. D. G., Wirbel, J., Cagnina, D., Catozzi, C., Dallavilla, T., Borgo, F., Fazio, N., Romario, U. F., Petz, W. L., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01180-9 · Cited by 19
Piawah, S., Kyaw, T. S., Trepka, K. R., Stewart, A. L., Mora, R. V., Stanfield, D., Levine, K., Blarigan, E. L. V., Venook, A. P., Turnbaugh, P. J., et al. (2023) · Cancers · doi:10.3390/cancers15184546 · Cited by 16
Metabolomics analyses of cancer tissue from patients with colorectal cancer
Kang, C., Zhang, J., Xue, M., Li, X., Ding, D., Wang, Y., Jiang, S., Chu, F., Gao, Q., & Zhang, M. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13106 · Cited by 17
Shimomura, Y., Sugi, Y., Kume, A., Tanaka, W., Yoshihara, T., Matsuura, T., Komiya, Y., Ogata, Y., Suda, W., Hattori, M., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05123-22 · Cited by 16
Kan, H. X., Cao, Y., Ma, Y., Zhang, Y. L., Wang, J., Li, J., & Li, J. N. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13247 · Cited by 17
Self-citationLuo, M. (2024) · American Journal of Cancer Research · doi:10.62347/myza2640 · Cited by 19
Dadashi, M., Hajikhani, B., Faghihloo, E., Owlia, P., Yaslianifard, S., Goudarzi, M., Nasiri, M. J., & Fallah, F. (2020) · Infectious Disorders - Drug Targets · doi:10.2174/1871526520666200720113004 · Cited by 17
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Søreide, K. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.028 · Cited by 17
Löwenmark, T., Köhn, L., Kellgren, T. G., Rosenbaum, W., Bronnec, V., Löfgren‐Burström, A., Zingmark, C., Larsson, P. G., Dahlberg, M. L., Schroeder, B. O., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05720-8 · Cited by 19
The rise and evolving role of Fusobacterium nucleatum subspecies
Wolf, M., Steinberg, T., Scholz, K. J., Kruse, A., Rezasoltani, S., Conrads, G., Al‐Ahmad, A., & Cieplik, F. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100414 · Cited by 15
Li, Q., Luo, W., Li, X., Xu, X., Peng, X., Cheng, L., Zhou, X., & Zheng, X. M. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2544169 · Cited by 18
The immune microenvironment of pathogen-associated cancers and current clinical therapeutics
Wei, X., Feng, H., Zhu, Y.-Y., Guo, S.-J., Wang, H., Li, M., & Mei, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02448-x · Cited by 20
Li, J., Zhang, C., Huang, X., Sun, H., Yang, L., Liu, H., Zhang, L., Wu, N., Xie, Y., Qi, J., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.02.001 · Cited by 19
Janati, A. I., Karp, I., Sabri, H., & Emami, E. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1031-7 · Cited by 16
Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy
Buono, A. D., Gaiani, F., Poliani, L., Correale, C., & Laghi, L. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121333 · Cited by 16
Zhou, Z., Wang, Y., Ji, R., Zhang, D., Ma, C., Ma, W., Ma, Y., Jiang, X., Du, K., Zhang, R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841918 · Cited by 16
Takenaka, I. K. T. M., Bartelli, T. F., Defelicibus, A., Sendoya, J. M., Golubicki, M., Robbio, J., Serpa, M. S., Branco, G. P., Santos, L. B. C., Claro, L. C. L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809441 · Cited by 17
Villar-Ortega, P., Ruíz, M. E., Gutiérrez-Soto, M., Jiménez, M. R.-C., Navarro‐Marí, J. M., & Fernández, J. G. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.02.007 · Cited by 17
Zhao, M. M., Lau, M. C., Haruki, K., Väyrynen, J. P., Gurjao, C., Väyrynen, S. A., Costa, A. D., Borowsky, J., Fujiyoshi, K., Arima, K., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00406-8 · Cited by 18
Self-citationXie, Z., Zhu, R., Huang, X., Yao, F., Jin, S., Huang, Q., Wang, D., Li, H., Wang, Q., Long, H., et al. (2023) · Oncology Letters · doi:10.3892/ol.2023.13944 · Cited by 17
Tumor-associated microbiome features of metastatic colorectal cancer and clinical implications
An, H. J., Partha, M. A., Lee, H., Lau, B. T., Pavlichin, D. S., Almeda, A. F., Hooker, A. C., Shin, G. W., & Ji, H. P. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1310054 · Cited by 16
Functional links between the microbiome and the molecular pathways of colorectal carcinogenesis
Permain, J., Hock, B. D., Eglinton, T. I., & Purcell, R. V. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10215-5 · Cited by 17
Mucinous Adenocarcinoma of the Rectum: A Whole Genome Sequencing Study
Reynolds, I. S., Thomas, V., O’Connell, E., Fichtner, M. W., McNamara, D. A., Kay, E. W., Prehn, J. H. M., Burke, J. P., & Furney, S. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01682 · Cited by 18
Harnessing Tissue Engineering Tools to Interrogate Host-Microbiota Crosstalk in Cancer
Udayasuryan, B., Nguyen, T. T. D., Slade, D. J., & Verbridge, S. S. (2020) · iScience · doi:10.1016/j.isci.2020.101878 · Cited by 15
Dong, Z., Zhang, C., Zhao, Q., Huangfu, H., Xue, X., Wen, S., Wu, Y., Gao, W., & Wang, B. (2021) · Journal of Cancer · doi:10.7150/jca.54221 · Cited by 16
Chu, Y. L., Georgeson, P., Clendenning, M., Mahmood, K., Walker, R., Como, J., Joseland, S. L., Preston, S., Rice, T., Lynch, B. M., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105661 · Cited by 15
Advancements in understanding tumor‑resident bacteria and their application in cancer therapy
Luo, Y., Huang, X., Wang, R., Lin, Y., Sun, J., Li, K., Wang, D. Y., Yan, Y., & Qiao, Y. (2025) · Military Medical Research · doi:10.1186/s40779-025-00623-1 · Cited by 16
Lauricella, S., Brucchi, F., Cirocchi, R., Cassini, D., & Vitellaro, M. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110552 · Cited by 19
Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy
Jia, J., Gao, W., Wang, C., Liu, L., Li, Y., Sun, Z., Yang, C., Chen, Y., Yu, H., & Cheng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08211-w · Cited by 18
Datorre, J. G., de Carvalho, A. C., dos Reis, M. B., dos Reis, M., Matsushita, M., Santos, F. A., Guimarães, D. P., & Reis, R. M. (2022) · Diagnostics · doi:10.3390/diagnostics12010114 · Cited by 15
Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far
Prasad, S. K., Bhat, S., Shashank, D., Akshatha, C. R., Sindhu, R., Rachtanapun, P., Devegowda, D., Santhekadur, P. K., & Sommano, S. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836004 · Cited by 15
Comprehensive analysis of microbiota signature across 32 cancer types
Yang, X., An, H., He, Y., Fu, G., & Jiang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1127225 · Cited by 15
McGregor, A. K., Chan, A., Schroeder, M. D., Do, L. T. M., Saini, G., Murphy, M. E. P., & Wolthers, K. R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104902 · Cited by 13
Self-citationClinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer
Matsumiya, Y., Suenaga, M., Ishikawa, T., Kudo, T., Nakagawa, T., Okamoto, K., Tokunaga, M., Hurtado, C., Yamada, Y., Oka, K., et al. (2023) · Anaerobe · doi:10.1016/j.anaerobe.2023.102784 · Cited by 15
A bibliometric and visualized in oral microbiota and cancer research from 2013 to 2022
Gu, Z., & Liu, Y. (2024) · Discover Oncology · doi:10.1007/s12672-024-00878-5 · Cited by 15
Crowley, C., Selvaraj, A., Hariharan, A., Healy, C. M., & Moran, G. P. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001217 · Cited by 15
Ji, G., Zhao, J., Si, X., & Song, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115345 · Cited by 16
Wu, Y., Xiong, J., Zhan, C.-N., & Xu, H. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106889 · Cited by 17
Fusobacterium nucleatum in Colorectal Cancer: Ally Mechanism and Targeted Therapy Strategies
Lu, J., Wei, W., & Zheng, D. (2025) · Research · doi:10.34133/research.0640 · Cited by 17
Dewan, A., Tattoli, I., & Mascellino, M. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146958 · Cited by 16
RetractedSomerman, M. J., & Mouradian, W. E. (2020) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2020.599214 · Cited by 16
Disparities in Surgical Oncology: Management of Advanced Cancer
Nizam, W., Yeo, H., Obeng‐Gyasi, S., Brock, M. V., & Johnston, F. M. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10275-9 · Cited by 16
The Unfolding Story of ATF6, Microbial Dysbiosis, and Colorectal Cancer
Lavoie, S., & Garrett, W. S. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.011 · Cited by 15
Self-citationFrom colon wall to tumor niche: Unraveling the microbiome’s role in colorectal cancer progression
Garcı́a, G., Sichel, L. S., López, M. D. C., Hernández, Y., Arteaga, E. G., Rodríguez, M., Calvo, V. F., Fernández, L. T., & Cano, R. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311233 · Cited by 14
Worrisome Trends in Young-Onset Colorectal Cancer: Now Is the Time for Action
Patel, G. L., & Patil, P. K. (2022) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-022-01496-9 · Cited by 14
Wang, H., Luo, K., Guan, Z., Li, Z., Xiang, J. Y., Ou, S., Tao, Y., Ran, S., Ye, J., Ma, T., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.811900 · Cited by 15
Łukaszewicz‐Zając, M., Pączek, S., & Mroczko, B. (2022) · Cancers · doi:10.3390/cancers14092307 · Cited by 14
Xie, Y., Jiao, X., Zeng, M., Fan, Z., Li, X., Yuan, Y., Zhang, Q., & Xia, Y. (2022) · Cancer Management and Research · doi:10.2147/cmar.s382464 · Cited by 14
Xiao, J., Wang, J., Zhou, C., & Luo, J. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s420614 · Cited by 14
Pan, Z., Zhou, C., Bai, X., Wang, F., Hong, J., Fang, J., Huang, Y., & Sheng, C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00281 · Cited by 14
Dynamic interplay of intratumoral microbiota within the colorectal cancer microenvironment
Wu, Y., Wang, P., Zhao, X., Liu, T., Situ, B., & Zheng, L. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230100 · Cited by 14
Microbiomes in pancreatic cancer can be an accomplice or a weapon
Guo, X., Wang, P., Li, Y., Chang, Y., & Wang, X. S. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104262 · Cited by 15
Wei, Z., Pan, J., & Ye, G. (2024) · The Journal of Microbiology · doi:10.1007/s12275-023-00100-1 · Cited by 14
L‑fucose ameliorates the carcinogenic properties of Fusobacterium nucleatum in colorectal cancer
Duan, C., Tang, X., Wang, W., Qian, W., Fu, X., Deng, X., Han, C., & Hou, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12404 · Cited by 14
Li, Y., Liu, J., Cai, X., Li, H., Cheng, Y., Dong, X.-H., Yu, W. J., & Fu, X. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103466 · Cited by 14
Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches
Pleguezuelos‐Manzano, C., Puschhof, J., & Clevers, H. C. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-095211 · Cited by 15
Hilmi, M., Neuzillet, C., Lefèvre, J. H., Svrcek, M., Vacher, S., Benhaïm, L., Dartigues, P., Samalin, E., Lazartigues, J., Emile, J., et al. (2022) · Cancers · doi:10.3390/cancers14071606 · Cited by 14
Berbert, L., Santos, A., Magro, D. O., Guadagnini, D., Assalin, H. B., Lourenço, L. H., Martinez, C. A. R., Saad, M. J. A., & Coy, C. S. R. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e11832 · Cited by 14
Secretory IgA dysfunction underlies poor prognosis in Fusobacterium -infected colorectal cancer
Choi, I., Kim, K., Kim, S. C., Park, D., Nam, K. T., Cha, J. H., Baek, S., Cha, J., Jo, H.-Y., Jung, M., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2528428 · Cited by 14
Self-citationImmune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology
Wallace, K., Nahas, G. J. E., Bookhout, C. E., Thaxton, J. E., Lewin, D., Nikolaishvili‐Feinberg, N., Cohen, S. M., Brazeal, J. G., Hill, E. G., Wu, J. D., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0592 · Cited by 13
Grape Processing Waste: Effects on Inflammatory Bowel Disease and Colorectal Cancer
Laurindo, L. F., Direito, R., Otoboni, A. M. M. B., Goulart, R. A., Quesada, K. R., & Barbalho, S. M. (2023) · Food Reviews International · doi:10.1080/87559129.2023.2168281 · Cited by 13
Pani, G. (2023) · Cancers · doi:10.3390/cancers15092583 · Cited by 16
Metadata
- Authors
- Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A. D., Giannakis, M., Bullman, S., Milner, D. A., Baba, H., Giovannucci, E. L., Garraway, L. A., Freeman, G. J., Dranoff, G., Garrett, W. S., Huttenhower, C., Meyerson, M., Meyerhardt, J. A., Chan, A. T., Fuchs, C. S., & Ogino, S.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Kumamoto University (JP)
- Corresponding author
- Ogino, Shuji
- ORCID
- Mima, Kosuke
- Nishihara, Reiko
- Qian, Zhi Rong
- Cao, Yin
- Sukawa, Yasutaka
- Nowak, Jonathan A
- Yang, Juhong
- Dou, Ruoxu
- Masugi, Yohei
- Song, Mingyang
- Kostic, Aleksandar D
- Giannakis, Marios
- Bullman, Susan
- Milner, Danny A
- Baba, Hideo
- Giovannucci, Edward L
- Garraway, Levi A
- Freeman, Gordon J
- Dranoff, Glenn
- Garrett, Wendy S
- Huttenhower, Curtis
- Meyerson, Matthew
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Fuchs, Charles S
- Ogino, Shuji
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-08-26
- Volume
- 65
- Issue
- 12
- Pages
- 1973-1980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4769120
- OpenAlex
- W2199896469
- Cited by
- 1,080
- References
- 53
- Citations by year
- 2026: 108 · 2025: 116 · 2024: 131 · 2023: 119 · 2022: 141 · 2021: 140 · 2020: 105 · 2019: 71 · 2018: 64 · 2017: 47 · 2016: 34 · 2015: 4
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR001100)
- National Cancer Institute (P50CA127003, R01CA151993, R01CA118553, R01CA137178, R35CA197735, P01CA087969, R01CA169141, K07CA122826, P01CA055075, UM1CA186107, UM1CA167552, K07CA190673, R01CA154426)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, rectal cancer, colon cancer, prognosis, colorectal cancer-specific mortality, tumor microbiome, microsatellite instability, CpG island methylator phenotype, BRAF mutation, prognostic factors, gut microbiota, antitumor immunity
- MeSH terms
- Aged, Carcinoma, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Phenotype, Prognosis, Prospective Studies, Research Design, Biomarkers, Tumor, Colorectal Neoplasms, Databases, Factual, Proto-Oncogene Proteins p21(ras), Fusobacterium nucleatum, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins B-raf, Kaplan-Meier Estimate, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
